European equities traded in the US as American depositary receipts were slightly lower late Wednesday morning, declining 0.14% to 1,346.88 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical firm DBV Technologies (DBVT), which rose 3.3% and 2.1%, respectively. They were followed by software firm SAP (SAP) and internet advertising company Criteo (CRTO), which were up 1.8% and 1.6%, respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and pharmaceutical company Ascendis Pharma (ASND), which fell 6.4% and 5.7% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Genfit (GNFT), which lost 4% and 3.7% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Adaptimmune Therapeutics (ADAP), which increased 3.3% and 0.9% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and hospitality company InterContinental Hotels Group (IHG), which were up 0.8% and 0.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Akari Therapeutics (AKTX), which dropped 6.4% and 3.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and utilities company National Grid (NGG), which were down 2.3% and 2.1% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。